Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1507Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REGNO:BG0120004 | - |
| dc.date.accessioned | 2023-10-18T06:27:38Z | - |
| dc.date.available | 2023-10-18T06:27:38Z | - |
| dc.date.issued | 2023-10 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1507 | - |
| dc.description.abstract | BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with significant morbidity and mortality. The aim of the present stusy was to evaluate the role of HNC-LL score as an early predictor of COVID-19 severity and to further compare its effectiveness with known scores such as CURB-65, MuLBSTA, Neutrophil to Lymphocyte ratio. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | COVID-19, HNC-LL, screening, early diagnosis disease severity, outcome | en_US |
| dc.title | “To study hnc-ll as a potential score For predicting severity in covid-19 Patients - a one year hospital based Cross sectional study in kles Dr.prabhakar kore hospital and medical Research centre, belagavi.” | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | General Medicine MD | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BG0120004.pdf | 3.91 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.